ArticleCancer2019

Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.

Sean Khozin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.